BlackRock Institutional Trust’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $1.33M | Sell |
308,243
-3
| -0% | -$13 | ﹤0.01% | 3195 |
|
|
2016
Q3 | $3.03M | Buy |
308,246
+3,901
| +1% | +$38.4K | ﹤0.01% | 2887 |
|
|
2016
Q2 | $1.72M | Sell |
304,345
-132,805
| -30% | -$751K | ﹤0.01% | 3088 |
|
|
2016
Q1 | $3.33M | Sell |
437,150
-27,388
| -6% | -$209K | ﹤0.01% | 2830 |
|
|
2015
Q4 | $6.19M | Sell |
464,538
-11,181
| -2% | -$149K | ﹤0.01% | 2595 |
|
|
2015
Q3 | $7.82M | Sell |
475,719
-105,589
| -18% | -$1.74M | ﹤0.01% | 2448 |
|
|
2015
Q2 | $13M | Buy |
581,308
+105
| +0% | +$2.36K | ﹤0.01% | 2229 |
|
|
2015
Q1 | $5.68M | Buy |
581,203
+57,516
| +11% | +$562K | ﹤0.01% | 2707 |
|
|
2014
Q4 | $5.97M | Buy |
523,687
+7,615
| +1% | +$86.8K | ﹤0.01% | 2651 |
|
|
2014
Q3 | $5.95M | Buy |
516,072
+44,934
| +10% | +$518K | ﹤0.01% | 2605 |
|
|
2014
Q2 | $9.16M | Buy |
471,138
+104,697
| +29% | +$2.04M | ﹤0.01% | 2487 |
|
|
2014
Q1 | $6.57M | Buy |
366,441
+48,896
| +15% | +$877K | ﹤0.01% | 2665 |
|
|
2013
Q4 | $3.35M | Buy |
317,545
+77,106
| +32% | +$814K | ﹤0.01% | 2952 |
|
|
2013
Q3 | $2.97M | Buy |
240,439
+31,039
| +15% | +$384K | ﹤0.01% | 2950 |
|
|
2013
Q2 | $1.97M | Buy |
+209,400
| New | +$1.97M | ﹤0.01% | 3071 |
|